Indication: Glossitis, Stomatitis, Cheilosis, Beriberi, Polyneuritis etc.Dosage & Administration:Capsule: 1-2 capsule 3 times daily or as directed by the physician.Syrup: 2-3 teaspoonful’s daily. Injection: 2 ml daily IV or IM.Preparation: B-50® Forte capsule: Box containing 25x1..
Indication: Glossitis, Stomatitis, Cheilosis, Beriberi, Polyneuritis etc.Dosage & Administration:Capsule: 1-2 capsule 3 times daily or as directed by the physician.Syrup: 2-3 teaspoonful’s daily. Injection: 2 ml daily IV or IM.Preparation: B-50® Forte capsule: Box containing 25x1..
Mupirocin 2% w/w in a water soluble polyethylene glycol base: topical ointment 10gm Indication:Topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes.Dosage & Administration:A small amount of ointment should be applied to the affected area three times daily. ..
Febuxostat INN 40mg & 80mg/tablet.40mg x 30's pack: 360.00 MRP10 Pcs Tablet: 120.00 MRP..Indication:BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the treatment of asymptomatic hyperuricemia.Dosage & Administration:Bar..
Febuxostat INN 40mg & 80mg/tablet.40mg x 30's Indication:BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the treatment of asymptomatic hyperuricemia.Dosage & Administration:BarifTM is recommended at 40 mg or 8..
Febuxostat INN 40mg & 80mg/tablet.80mg x 10'sIndication:BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the treatment of asymptomatic hyperuricemia.Dosage & Administration:BarifTM is recommended at 40 mg or 80 mg o..
Indication: Seasonal & perennial allergic rhinitis including hay fever & non-allergic (vasomotor) rhinitis.Dosage & Administration:Adults : 02 sprays in each nostril twice daily.Children (6 to 12 years of age) : 01 spray in each nostril twice daily. Children under 6 years of age : Not recommend..
Indication: BufocortTM Cozycaps are indicated in the regular treatment of asthma. They are also indicated in the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD), with a history of repeated exacerbations despite regular therapy with long-acting bronchodilators.&..
Indication: BufocortTM Cozycaps are indicated in the regular treatment of asthma. They are also indicated in the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD), with a history of repeated exacerbations despite regular therapy with long-acting bronchodilators.&..